selected publications academic article Wang, J., McGrail, D. J., Bhupal, P. K., Zhang, W., Lin, K., Ku, Y., ... Tsai, R (2020). Nucleostemin Modulates Outcomes of Hepatocellular Carcinoma via a Tumor Adaptive Mechanism to Genomic Stress. MOLECULAR CANCER RESEARCH. 18(5), 723-734.
principal investigator on Genome-Wide DNA Methylation Markers for Predicting the Risk of Liver Cancer in Non- Alcoholic Fatty Livers awarded by Cancer Prevention and Research Institute of Texas - (Austin, Texas, United States) 2020 Chemoablation of high-risk oral premalignant lesions for sustained cancer prevention awarded by Cancer Prevention and Research Institute of Texas - (Austin, Texas, United States) 2017 - 2020 Aging Effect on Genome Maintenance during Hepatocyte Regeneration awarded by National Institutes of Health - (Bethesda, Maryland, United States) 2016 - 2019 Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma awarded by National Institutes of Health - (Bethesda, Maryland, United States) 2015 - 2018 Nucleostemin: A New Tumor Addictive Mechanism, Outcome Predictor, and Therapeutic Target for Hepatocellular Carcinoma awarded by Cancer Prevention and Research Institute of Texas - (Austin, Texas, United States) 2020 -
mailing address Texas A&M Health Science Center Ibt Center For Translational Cancer Research 1201 TAMUS Houston, TX 77030-3303 USA